| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.22 | 0.003 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.005 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.16 | 0.005 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.22 | 0.005 |